Is it time to redefine the management of febrile neutropenia in cancer patients?

Elias J. Anaissie; Saroj Vadhan-Raj

doi:10.1016/S0002-9343(99)80366-0

Is it time to redefine the management of febrile neutropenia in cancer patients?

Elias J. Anaissie, Saroj Vadhan-Raj

Sarcoma Medical Oncology

Research output: Contribution to journal › Editorial › peer-review

28 Scopus citations

Original language	English (US)
Pages (from-to)	221-223
Number of pages	3
Journal	The American journal of medicine
Volume	98
Issue number	3
DOIs	https://doi.org/10.1016/S0002-9343(99)80366-0
State	Published - Mar 1995

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0002-9343(99)80366-0

Cite this

@article{dafa329ff49a4b2dad384c1fb9fcd255,

title = "Is it time to redefine the management of febrile neutropenia in cancer patients?",

author = "Anaissie, {Elias J.} and Saroj Vadhan-Raj",

year = "1995",

month = mar,

doi = "10.1016/S0002-9343(99)80366-0",

language = "English (US)",

volume = "98",

pages = "221--223",

journal = "The American journal of medicine",

issn = "0002-9343",